Global Eosinophilic Esophagitis Drug Market Research Report 2023(Status and Outlook)
Report Overview
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
The Global Eosinophilic Esophagitis Drug Market Size was estimated at USD 123.00 million in 2022 and is projected to reach USD 178.93 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Eosinophilic Esophagitis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Eosinophilic Esophagitis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Eosinophilic Esophagitis Drug market in any manner.
Global Eosinophilic Esophagitis Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Market Segmentation (by Type)
Budesonide
Fluticasone
Others
Market Segmentation (by Application)
Retail Pharmacies
Hospital Pharmacies
Online Platform
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Eosinophilic Esophagitis Drug Market
Overview of the regional outlook of the Eosinophilic Esophagitis Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Eosinophilic Esophagitis Drug
- 1.2 Key Market Segments
- 1.2.1 Eosinophilic Esophagitis Drug Segment by Type
- 1.2.2 Eosinophilic Esophagitis Drug Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Eosinophilic Esophagitis Drug Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Eosinophilic Esophagitis Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Eosinophilic Esophagitis Drug Market Competitive Landscape
- 3.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturers (2018-2023)
- 3.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Eosinophilic Esophagitis Drug Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Eosinophilic Esophagitis Drug Sales Sites, Area Served, Product Type
- 3.6 Eosinophilic Esophagitis Drug Market Competitive Situation and Trends
- 3.6.1 Eosinophilic Esophagitis Drug Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Eosinophilic Esophagitis Drug Industry Chain Analysis
- 4.1 Eosinophilic Esophagitis Drug Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Eosinophilic Esophagitis Drug Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Eosinophilic Esophagitis Drug Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2018-2023)
- 6.3 Global Eosinophilic Esophagitis Drug Market Size Market Share by Type (2018-2023)
- 6.4 Global Eosinophilic Esophagitis Drug Price by Type (2018-2023)
- 7 Eosinophilic Esophagitis Drug Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Eosinophilic Esophagitis Drug Market Sales by Application (2018-2023)
- 7.3 Global Eosinophilic Esophagitis Drug Market Size (M USD) by Application (2018-2023)
- 7.4 Global Eosinophilic Esophagitis Drug Sales Growth Rate by Application (2018-2023)
- 8 Eosinophilic Esophagitis Drug Market Segmentation by Region
- 8.1 Global Eosinophilic Esophagitis Drug Sales by Region
- 8.1.1 Global Eosinophilic Esophagitis Drug Sales by Region
- 8.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Eosinophilic Esophagitis Drug Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Eosinophilic Esophagitis Drug Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Eosinophilic Esophagitis Drug Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 AstraZeneca
- 9.1.1 AstraZeneca Eosinophilic Esophagitis Drug Basic Information
- 9.1.2 AstraZeneca Eosinophilic Esophagitis Drug Product Overview
- 9.1.3 AstraZeneca Eosinophilic Esophagitis Drug Product Market Performance
- 9.1.4 AstraZeneca Business Overview
- 9.1.5 AstraZeneca Eosinophilic Esophagitis Drug SWOT Analysis
- 9.1.6 AstraZeneca Recent Developments
- 9.2 GSK
- 9.2.1 GSK Eosinophilic Esophagitis Drug Basic Information
- 9.2.2 GSK Eosinophilic Esophagitis Drug Product Overview
- 9.2.3 GSK Eosinophilic Esophagitis Drug Product Market Performance
- 9.2.4 GSK Business Overview
- 9.2.5 GSK Eosinophilic Esophagitis Drug SWOT Analysis
- 9.2.6 GSK Recent Developments
- 9.3 Bayer
- 9.3.1 Bayer Eosinophilic Esophagitis Drug Basic Information
- 9.3.2 Bayer Eosinophilic Esophagitis Drug Product Overview
- 9.3.3 Bayer Eosinophilic Esophagitis Drug Product Market Performance
- 9.3.4 Bayer Business Overview
- 9.3.5 Bayer Eosinophilic Esophagitis Drug SWOT Analysis
- 9.3.6 Bayer Recent Developments
- 9.4 Adare Pharmaceuticals
- 9.4.1 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Basic Information
- 9.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Overview
- 9.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Market Performance
- 9.4.4 Adare Pharmaceuticals Business Overview
- 9.4.5 Adare Pharmaceuticals Eosinophilic Esophagitis Drug SWOT Analysis
- 9.4.6 Adare Pharmaceuticals Recent Developments
- 9.5 DBV Technologies
- 9.5.1 DBV Technologies Eosinophilic Esophagitis Drug Basic Information
- 9.5.2 DBV Technologies Eosinophilic Esophagitis Drug Product Overview
- 9.5.3 DBV Technologies Eosinophilic Esophagitis Drug Product Market Performance
- 9.5.4 DBV Technologies Business Overview
- 9.5.5 DBV Technologies Eosinophilic Esophagitis Drug SWOT Analysis
- 9.5.6 DBV Technologies Recent Developments
- 9.6 Dr. Falk Pharma
- 9.6.1 Dr. Falk Pharma Eosinophilic Esophagitis Drug Basic Information
- 9.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Overview
- 9.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Market Performance
- 9.6.4 Dr. Falk Pharma Business Overview
- 9.6.5 Dr. Falk Pharma Recent Developments
- 9.7 Quorum Innovations
- 9.7.1 Quorum Innovations Eosinophilic Esophagitis Drug Basic Information
- 9.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Product Overview
- 9.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Product Market Performance
- 9.7.4 Quorum Innovations Business Overview
- 9.7.5 Quorum Innovations Recent Developments
- 9.8 Takeda
- 9.8.1 Takeda Eosinophilic Esophagitis Drug Basic Information
- 9.8.2 Takeda Eosinophilic Esophagitis Drug Product Overview
- 9.8.3 Takeda Eosinophilic Esophagitis Drug Product Market Performance
- 9.8.4 Takeda Business Overview
- 9.8.5 Takeda Recent Developments
- 9.9 Calypso
- 9.9.1 Calypso Eosinophilic Esophagitis Drug Basic Information
- 9.9.2 Calypso Eosinophilic Esophagitis Drug Product Overview
- 9.9.3 Calypso Eosinophilic Esophagitis Drug Product Market Performance
- 9.9.4 Calypso Business Overview
- 9.9.5 Calypso Recent Developments
- 9.10 Celgene
- 9.10.1 Celgene Eosinophilic Esophagitis Drug Basic Information
- 9.10.2 Celgene Eosinophilic Esophagitis Drug Product Overview
- 9.10.3 Celgene Eosinophilic Esophagitis Drug Product Market Performance
- 9.10.4 Celgene Business Overview
- 9.10.5 Celgene Recent Developments
- 9.11 Regeneron
- 9.11.1 Regeneron Eosinophilic Esophagitis Drug Basic Information
- 9.11.2 Regeneron Eosinophilic Esophagitis Drug Product Overview
- 9.11.3 Regeneron Eosinophilic Esophagitis Drug Product Market Performance
- 9.11.4 Regeneron Business Overview
- 9.11.5 Regeneron Recent Developments
- 10 Eosinophilic Esophagitis Drug Market Forecast by Region
- 10.1 Global Eosinophilic Esophagitis Drug Market Size Forecast
- 10.2 Global Eosinophilic Esophagitis Drug Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Eosinophilic Esophagitis Drug Market Size Forecast by Country
- 10.2.3 Asia Pacific Eosinophilic Esophagitis Drug Market Size Forecast by Region
- 10.2.4 South America Eosinophilic Esophagitis Drug Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Eosinophilic Esophagitis Drug by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Eosinophilic Esophagitis Drug Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Eosinophilic Esophagitis Drug by Type (2024-2029)
- 11.1.2 Global Eosinophilic Esophagitis Drug Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Eosinophilic Esophagitis Drug by Type (2024-2029)
- 11.2 Global Eosinophilic Esophagitis Drug Market Forecast by Application (2024-2029)
- 11.2.1 Global Eosinophilic Esophagitis Drug Sales (K MT) Forecast by Application
- 11.2.2 Global Eosinophilic Esophagitis Drug Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook